Fitch v. State of Maryland

District Court, D. Maryland·Decided September 29, 2023·No. 1:18-cv-02817·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MARYLAND

KENNETH FITCH, et ai., * . Plaintiffs, " * v. * * Civil No. 18-2817 PJM STATE OF MARYLAND, et al, : Defendants. * □□ MEMORANDUM OPINION I. INTRODUCTION This is the final chapter in a case that arises from the State of Maryland’s attempt to transition certain retired state employees from a state-subsidized prescription drug benefit program to a combination of drug benefit programs available under new state programs and Part D of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Pub. L. No. 108-173, 117 Stat. 2066 (codified at 42 U.S.C. § 1395w-101 ef seg. (‘Part D”)). On October 16, 2018, the Court issued an Order granting Plaintiffs’ Motion for Preliminary Injunction. ECF No. 31. Thereafter, on July 19, 2023, the Court signed an Order granting Defendants’ Motion for □ Dissolution of the Preliminary Injunction, but deferring decision with respect to Defendants’

_ Motion for Summary Judgment pending consideration of whether Plaintiffs could state alternative claims of fraud or restitution against Defendants. ECF No. 220. Plaintiffs have provided additional briefing addressing possible alternative causes of action. See ECF No. 223. The Court now considers Defendants’ Motion for Summary Judgment. ECF No. 196. For the following reasons, Defendants’ Motion for Summary Judgment is now GRANTED as to both Plaintiffs’ original and new alternative claims. . □

Il. BACKGROUND

On June 29, 2023, the Court held a Hearing on Defendant’s Motion for Summary Judgment and Dissolution of Preliminary Injunction and also on Plaintiffs’ Motion for Leave to File Third Motion for Class Certification. ECF ‘No. 219. Shortly thereafter, the Court denied Plaintiffs’ Motion and granted Defendants’ Motion for Dissolution of the Preliminary Injunction, finding that there was no longer a substantial likelihood that Plaintiffs would prevail on the merits of their claim, given (1) that all of Plaintiffs” remaining claims clearly derived from the theory that the 2004 General Assembly created a contract with State employees with respect to the provision of prescription drug benefits but (2) the Fourth Circuit held with respect to other State employees that no such contract exists. ECF 220 at 8. The Court, however, deferred ruling on Defendants’ Motion for Summary Judgment and gave Plaintiffs leave to submit additional briefing as to possible alternative claims Plaintiffs’ Counsel ratsed for the first time at the Hearing, viz. causes of action for fraud and/or restitution. In doing so, the Court noted that, although Plaintiffs were continuing to claim irreparable injury based on prohibitive increases in the cost of prescription drugs, “[i]t appears that both the State’s creation of the Replacement Programs in 2019 and Congress’s changes to Part D in the Inflation Reduction Act should function to protect fixed-income retirees in much the same way as the State Program has.” ECF No. 220 at9-10.! □ Il. STANDARD OF REVIEW □

A court “shall grant summary judgment if the movant shows that there is no ‘genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.” Fed. R.

its July Opinion, the Court laid out in detail the relevant history of state and federal prescription □□□□□ coverage, particularly pertinent developments in State coverage and Part D of Medicare since 2019. See ECF No. 220 at 2-5. . .

,

Civ. P. 56(a) (emphasis added). A dispute over a material fact is genuine “if the evidence is such that a reasonable jury could return a verdict for the nonmoving party.” Anderson vy. Liberty Lobby, Inc., 477 U.S. 242, 248 (1986). “A party opposing a properly supported motion for summary judgment ‘may not rest upon the mere allegations or denials of [his] pleadings,’ but rather must ‘set forth specific facts showing that there is a genuine issue for trial.’” Bouchat v. Baltimore Ravens Football Club, Inc., 346 F.3d 514, 522 (4th Cir. 2003) (alteration in original) (quoting Fed. R. Civ. P. 56(e)). “Courts are required to view the facts and draw reasonable inferences ‘in the light most favorable to the party opposing the [summary judgment] motion.’” Scott v. Harris, 550 U.S. 372, 378 (2007) (quoting United States v. Diebold, Inc., 369 U.S. 654, 655 (1962) (per curiam). IV. ANALYSIS Plaintiffs’ original and alternative new claims cannot survive summary judgment. Even if the Court were to grant them leave to amend their Complaint this late in the day, such amendment would be futile.

A. Plaintiffs’ Original Claims As set out in the Court’s previous opinion and summarized here, Plaintiffs’ original claims, which remain pending, are not viable because (1) “Sections 2-508 and 2-509.1 do not create a contract between the State of Maryland and its employees or retirees,” AFSCME Maryland Council 3 vy. Maryland, 61 F.4th 143, 151 (4th Cir. 2023), and (2) it appears Plaintiffs will no longer be materially prejudiced if and when they move from the State’s program to Part D. To repeat, the Fourth Circuit ruled that the 2004 General Assembly did not form a contract with State employees. See id. As this Court found in turn, the Fourth Circuit’s finding disposes of

. 3

Plaintiffs’ original claims. See ECF 220 at 8. This is a sufficient ground for the Court to grant Defendants’ Motion for Summary Judgment with respect to Plaintiffs’ claims based on contract. "On addition; Plaintiffs have not shown that they will be materially prejudiced by the State “forcing” them to transition from the State’s program to Part D. In their Initial Complaint, Plaintiffs made what the Court took to be well-founded claims about how moving from the State’s program to Medicare Part D could cost individual State employees as much as thousands of dollars per month. But as discussed in the Court’s July Opinion, since the passage of the 2019 Programs, covering among other things drug benefits, and especially following the passage of the federal Inflation Recovery Act, which also addresses prescription drug coverage, this risk appears to have been all but eliminated. See ECF No. 220 at 9-10. The State’s 2019 Programs guarantee its retirees □ coverage of the same annual out-of-pocket costs that they have become entitled to through their years of service, and the Inflation Reduction Act codifies caps on the cost of prescription drugs - that are nearly as generous for seniors nationwide. See id. If the State were to implement its 2019 Programs’ reimbursement plan in a manner that denied individuals the coverage required by either the 2019 Programs or Medicare Part D, that might well be grounds for a new claim. But until then, □

the harm Plaintiffs allege is wholly speculative. See Lujan v. Defs. of Wildlife, 504 U.S. 555, 560 (stating that injury must be “actual or imminent, not conjectural or hypothetical”) (internal quotation marks and citations omitted). B. Plaintiffs’ Alternative New Fraud Claims □ The Court considers the new causes of action Plaintiffs have put forth in their supplemental briefing; that is, that the State acted fraudulently with respect to provision of prescription drug benefits and Plaintiffs are therefore entitled to restitution.

Free access — add to your briefcase to read the full text and ask questions with AI

Fitch v. State of Maryland, (D. Md. 2023).

Fitch v. State of Maryland (Fitch v. State of Maryland) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Gunter v. Atlantic Coast Line Railroad
200 U.S. 273 (Supreme Court, 1906)
United States v. Diebold, Inc.
369 U.S. 654 (Supreme Court, 1962)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Lujan v. Defenders of Wildlife
504 U.S. 555 (Supreme Court, 1992)
Lapides v. Board of Regents of Univ. System of Ga.
535 U.S. 613 (Supreme Court, 2002)
Scott v. Harris
550 U.S. 372 (Supreme Court, 2007)
Bouchat v. Baltimore Ravens Football Club, Inc.
346 F.3d 514 (Fourth Circuit, 2003)
Lerner v. Northwest Biotherapeutics
273 F. Supp. 3d 573 (D. Maryland, 2017)